Performant Financial Corporation Share Price

Equities

PFMT

US71377E1055

Business Support Services

Market Closed - Nasdaq 01:30:00 27/04/2024 am IST 5-day change 1st Jan Change
2.72 USD +4.62% Intraday chart for Performant Financial Corporation +5.84% -12.96%
Sales 2024 * 126M 10.52B Sales 2025 * 145M 12.06B Capitalization 209M 17.44B
Net income 2024 * -7M -584M Net income 2025 * 5M 417M EV / Sales 2024 * 1.66 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 1.45 x
P/E ratio 2024 *
-28.6 x
P/E ratio 2025 *
41.8 x
Employees 958
Yield 2024 *
-
Yield 2025 *
-
Free-Float 85.11%
More Fundamentals * Assessed data
Dynamic Chart
Performant Financial Acquires RecordsOne's AI Technology -- Shares Jump After Hours MT
Performant Financial Corporation Provides Revenue Guidance for the Full Year 2024 CI
Transcript : Performant Financial Corporation, Q4 2023 Earnings Call, Mar 12, 2024
Performant Financial Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
Earnings Flash (PFMT) PERFORMANT FINANCIAL CORPORATION Reports Q4 Revenue $32.6M, vs. Street Est of $31.6M MT
Earnings Flash (PFMT) PERFORMANT FINANCIAL CORPORATION Reports Q4 EPS $0.05, vs. Street Est of $0.02 MT
Performant Financial Corporation Appoints Dr. Shantanu Agrawal as A Member of the Board of Directors CI
Transcript : Performant Financial Corporation, Q3 2023 Earnings Call, Nov 07, 2023
Performant Financial Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Earnings Flash (PFMT) PERFORMANT FINANCIAL CORPORATION Posts Q3 Revenue $30M, vs. Street Est of $27.9M MT
Earnings Flash (PFMT) PERFORMANT FINANCIAL CORPORATION Reports Q3 EPS $0.01, vs. Street Est of $-0.02 MT
Performant Financial Corporation Announces Completion of Debt Refinancing CI
Performant Financial Gets Another CMS Contract From New York State's Office of Medicaid Inspector General MT
Performant Financial Corporation Wins New York State Medicaid RAC Contract CI
Transcript : Performant Financial Corporation, Q2 2023 Earnings Call, Aug 08, 2023
More news
1 day+4.62%
1 week+5.84%
Current month-7.48%
1 month-4.23%
3 months-3.89%
6 months+23.36%
Current year-12.96%
More quotes
1 week
2.55
Extreme 2.55
2.82
1 month
2.38
Extreme 2.38
3.00
Current year
2.38
Extreme 2.38
3.23
1 year
2.00
Extreme 2
3.61
3 years
1.72
Extreme 1.72
5.29
5 years
0.00
Extreme 0
5.29
10 years
0.00
Extreme 0
10.97
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 01/12/01
Director of Finance/CFO - 01/14/01
Chairman 59 01/04/01
Members of the board TitleAgeSince
Director/Board Member 64 01/12/01
Chairman 59 01/04/01
Director/Board Member 42 05/20/05
More insiders
Date Price Change Volume
26/24/26 2.72 +4.62% 177,286
25/24/25 2.6 -2.99% 125,048
24/24/24 2.68 -3.25% 149,756
23/24/23 2.77 +4.53% 164,045
22/24/22 2.65 +3.11% 144,497

Delayed Quote Nasdaq, April 27, 2024 at 01:30 am IST

More quotes
Performant Financial Corporation supports healthcare payers in identifying, preventing, and recovering waste and improper payments by leveraging advanced technology, analytics and data assets. The Company works with national and regional healthcare payers to provide eligibility-based, also known as coordination-of-benefits (COB) services, as well as claims-based services, which includes the audit and identification of improperly paid claims. It also provides advanced reporting capabilities, support services, customer care, and stakeholder training programs designed to mitigate future instances of improper payments. The Company offers these services in both government and commercial healthcare markets. It provides audit, eligibility, and recovery services to identify improper healthcare payments. The Company provides its services to government and private clients, such as private healthcare and Center for Medicare and Medicaid Services (CMS).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2.72 USD
Average target price
7.5 USD
Spread / Average Target
+175.74%
Consensus